Who
In numbers
- Trades disclosed
- 33
- Buys
- 15
- Sells
- 0
- Bought
- $156K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 15 Sep 2017
- Last trade
- 15 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 17 Sep 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $6,071976 at $6.22 | filing |
| 15 Sep 2026filed 17 Sep 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $6,071976 at $6.22 | filing |
| 15 Jun 2026filed 17 Jun 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $6,059705 at $8.60 | filing |
| 15 Jun 2026filed 17 Jun 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $6,063705 at $8.60 | filing |
| 16 Mar 2026filed 18 Mar 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $5,5181,055 at $5.23 | filing |
| 16 Mar 2026filed 18 Mar 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $5,5181,055 at $5.23 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $21K3,955 at $5.22 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $21K3,955 at $5.22 | filing |
| 15 Dec 2025filed 17 Dec 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $5,265805 at $6.54 | filing |
| 6 Nov 2025filed 10 Nov 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code A | $105K13,531 at $7.76 | filing |
| 16 Sep 2025filed 18 Sep 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $4,883450 at $10.85 | filing |
| 13 Jun 2025filed 17 Jun 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $4,758370 at $12.86 | filing |
| 13 Jun 2025filed 17 Jun 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $1159 at $12.78 | filing |
| 16 Dec 2024filed 17 Dec 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $3,632227 at $16.00 | filing |
| 7 Nov 2024filed 12 Nov 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Code A | $105K7,819 at $13.43 | filing |
| 17 Sep 2024filed 17 Sep 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $3,557345 at $10.31 | filing |
| 17 Sep 2024filed 17 Sep 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $616 at $10.23 | filing |
| 14 Jun 2024filed 18 Jun 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $3,506475 at $7.38 | filing |
| 14 Jun 2024filed 18 Jun 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $10314 at $7.36 | filing |
| 15 Mar 2024filed 18 Mar 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $3,080440 at $7.00 | filing |
News
Lifevantage (NASDAQ:LFVN) Stock Price Breaks Below 200-Day Moving Average Following Analyst DowngradeLFVN · dailypolitical.com · 21 Oct 2026LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)LFVN · manilatimes.net · 12 Oct 2026
0 headlines in the last 90 days name Darwin Lewis; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.